GPR55 and bone disorder: Another study found that CBD and other GPR55 antagonists can inhibit bone resorption in vivo; additionally, GPR55 ligands affect osteoclast formation in vitro, suggesting a potential therapeutic role for CBD and minor cannabinoids in bone disorders [17,66].